Tarsus Pharmaceuticals Inc (TARS) — Free Cash Flow Generation Index

Latest as of December 2025: 0.67x

Tarsus Pharmaceuticals Inc (TARS) has a Free Cash Flow Generation Index of 0.67x as of December 2025. Free cash flow of $12.97 Million represents 1% of operating cash flow ($19.33 Million). Read Tarsus Pharmaceuticals Inc total liabilities for a breakdown of total debt and financial obligations.

FCF Generation Index

0.67x
Free Cash Flow / Operating CF

Free Cash Flow

$12.97 Million
USD

Operating Cash Flow

$19.33 Million
USD

Capital Expenditures

$6.36 Million
USD

Tarsus Pharmaceuticals Inc Free Cash Flow Generation Index (2021–2021)

Historical FCF Generation Index trend for Tarsus Pharmaceuticals Inc across 1 annual periods. Explore Tarsus Pharmaceuticals Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Tarsus Pharmaceuticals Inc (2021–2021)

Year-by-year Free Cash Flow Generation Index for Tarsus Pharmaceuticals Inc. For the full company profile including market capitalisation, see Tarsus Pharmaceuticals Inc (TARS) total market value.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2021 0.84x $3.16 Million $3.75 Million $586.00K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).